Document is current
Any future updates will be listed below
-
Authors
Suntornlohanakul, Rabporn
Yeh, E. Ann https://orcid.org/0000-0002-5393-7417
- License Information
-
More Information
Article History
Accepted: 3 December 2024
First Online: 26 December 2024
Declarations:
:
: R.S. has no conflicts of interest to disclose. E.A.Y. has received research funding from NMSS, CMSC, CIHR, NIH, OIRM, SCN, CBMH Chase an Idea, SickKids Foundation, Rare Diseases Foundation, MS Scientific Foundation, McLaughlin Centre, Leong Center, Peterson Foundation, and Garry Hurvitz Centre for Brain and Mental Health. Investigator initiated research funding from Biogen. Scientific advisory: Hoffman-LaRoche, Alexion. DSMB: Pipeline Therapeutics. Speaker honoraria: Biogen, JHU, Saudi Epilepsy Society, NYU, MS-ATL; ACRS, PRIME, CNPS. CMSC, AAN, and OHRI. Co-Editor-in-Chief, MSARD. Governing Council: CANTRAIN. Steering Committee: Rare-Kids CAN.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: R.S. conducted the literature search, performed the literature review, and drafted the manuscript. E.A.Y. provided guidance throughout the process and critically revised the manuscript. Both authors have read and approved the final submitted manuscript and agree to be accountable for the work.
